PRAX SEC filings (2026)
CIK 1689548 · Pharmaceutical Preparations (SIC 2834) · incorporated in DE · fiscal year ends in December
510 filings on EDGAR since 2016 · 6 annual, 18 quarterly, 90 current · financial statements · earnings
What happened, last 12 months#
Every earnings release with its print, every report with its quarter, the other 8-Ks by the headline of the press release they furnish or by their items, the proxy statements, and each day an insider bought or sold — newest first, each line opening the filing on EDGAR. The index by form and year follows.
August 2026
- Aug 6EarningsEarnings release — EPS −$2.87 vs −$3.60 est. (+20.3%) 16.0%
- Aug 6ReportQuarterly report, Q2 2026 — net income −$83.7M, EPS −$2.87
July 2026
- Jul 78-K8-K · Other events
- Jul 28-K8-K · Change of auditor
June 2026
- Jun 298-K8-K · Other events
- Jun 24Insider saleDeSimone Jill (Director) sold 11,600 shares for $3.6M at $301.44–$315.71 under a 10b5-1 plan
- Jun 228-K8-K · Other events
- Jun 128-K8-K · Shareholder vote results
- Jun 18-K8-K · Other events
May 2026
- May 7EarningsEarnings release — EPS −$3.20 vs −$3.58 est. (+10.6%) 1.0%
- May 7ReportQuarterly report, Q1 2026 — net income −$92.6M, EPS −$3.20
April 2026
- Apr 30ProxyProxy · Additional proxy materials
- Apr 30ProxyProxy · Proxy statement
- Apr 148-K8-K · Other events
- Apr 68-K8-K · Other events
February 2026
January 2026
- Jan 88-K8-K · Directors or officers; compensation
- Jan 78-K8-K · Other events
- Jan 68-K8-K · Results of operations
December 2025
- Dec 298-K8-K · Other events
- Dec 118-K8-K · Other events
- Dec 88-K8-K · Other events
November 2025
October 2025
- Oct 218-K8-K · Regulation FD disclosure; Other events
Insider transactions#
What officers, directors and 10% holders reported on Forms 4 and 5 over the last 13 months, from the documents themselves: one insider’s trades of one kind on one day are one row, with the shares, the price range and the total as filed. Open-market buys and sells first; awards, exercises, tax withholding, gifts and employee-plan purchases are grouped below them.
Over the last 13 months insiders sold $3.6M in 1 sale and bought nothing on the open market; 51 other transactions (awards, exercises, tax withholding, gifts and plan purchases).
| Date | Insider |
|---|---|
| Jun 24, 2026Form 4 | DeSimone JillDirectorSold · $3.6M · 11,600 sh · 10b5-1 |
Awards, exercises, withholding and plan purchases · 51 transactions
| Date | Insider |
|---|---|
| Jul 8, 2026Form 4 | Souza MarcioChief Executive Officer · DirectorGift · $0 · 23,121 sh |
| Jun 24, 2026Form 4 | DeSimone JillDirectorExercise or conversion · $826K · 11,600 sh · 10b5-1 |
| Jun 24, 2026Form 4 | DeSimone JillDirectorExercise or conversion · Stock Option (Right to Buy) · $0 · 11,600 sh · 10b5-1 |
| Jun 10, 2026Form 4 | Norden GregoryDirectorAward · $0 · 1,371 sh |
| Jun 10, 2026Form 4 | KINDLER JEFFREY BDirectorAward · $0 · 1,371 sh |
| Jun 10, 2026Form 4 | MITCHELL DEAN JDirectorAward · $0 · 1,371 sh |
| Jun 10, 2026Form 4 | Cudkowicz Merit EsterDirectorAward · $0 · 1,371 sh |
| Jun 10, 2026Form 4 | DeSimone JillDirectorAward · $0 · 1,371 sh |
| Jun 10, 2026Form 4 | YOUNG WILLIAM DDirectorAward · $0 · 1,371 sh |
| Jun 10, 2026Form 4 | Chodakewitz JeffreyDirectorAward · $0 · 1,371 sh |
| Jun 10, 2026Form 4 | Arbuckle Stuart ADirectorAward · $0 · 1,371 sh |
| Jun 10, 2026Form 4 | Norden GregoryDirectorAward · Stock Option (Right to Buy) · $0 · 648 sh |
| Jun 10, 2026Form 4 | KINDLER JEFFREY BDirectorAward · Stock Option (Right to Buy) · $0 · 648 sh |
| Jun 10, 2026Form 4 | MITCHELL DEAN JDirectorAward · Stock Option (Right to Buy) · $0 · 648 sh |
| Jun 10, 2026Form 4 | Cudkowicz Merit EsterDirectorAward · Stock Option (Right to Buy) · $0 · 648 sh |
| Jun 10, 2026Form 4 | DeSimone JillDirectorAward · Stock Option (Right to Buy) · $0 · 648 sh |
| Jun 10, 2026Form 4 | YOUNG WILLIAM DDirectorAward · Stock Option (Right to Buy) · $0 · 648 sh |
| Jun 10, 2026Form 4 | Chodakewitz JeffreyDirectorAward · Stock Option (Right to Buy) · $0 · 648 sh |
| Jun 10, 2026Form 4 | Arbuckle Stuart ADirectorAward · Stock Option (Right to Buy) · $0 · 648 sh |
| May 14, 2026Form 4 | Mastrocola LaurenPrincipal Accounting OfficerAward · $21K · 127 sh |
| May 14, 2026Form 4 | Souza MarcioChief Executive Officer · DirectorAward · $21K · 126 sh |
| May 14, 2026Form 4 | Kelly Timothy EdwinChief Financial OfficerAward · $20K · 121 sh |
| May 14, 2026Form 4 | Sniecinski MeganChief Operating OfficerAward · $15K · 89 sh |
| May 14, 2026Form 4 | Nemiroff AlexGeneral Counsel and SecretaryAward · $13K · 78 sh |
| Feb 6, 2026Form 4 | KINDLER JEFFREY BDirectorAward · $0 · 1,166 sh |
| Feb 6, 2026Form 4 | Arbuckle Stuart ADirectorAward · $0 · 1,166 sh |
| Feb 6, 2026Form 4 | KINDLER JEFFREY BDirectorAward · Stock Option (Right to Buy) · $0 · 224 sh |
| Feb 6, 2026Form 4 | Arbuckle Stuart ADirectorAward · Stock Option (Right to Buy) · $0 · 224 sh |
| Jan 12, 2026Form 4 | Kelly Timothy EdwinChief Financial OfficerTax withholding · $260K · 943 sh |
| Jan 12, 2026Form 4 | Sniecinski MeganChief Operating OfficerTax withholding · $244K · 885 sh |
| Jan 12, 2026Form 4 | Nemiroff AlexGeneral Counsel and SecretaryTax withholding · $212K · 768 sh |
| Jan 12, 2026Form 4 | Mastrocola LaurenPrincipal Accounting OfficerTax withholding · $95K · 344 sh |
| Jan 10, 2026Form 4 | Souza MarcioChief Executive Officer · DirectorTax withholding · $1.2M · 4,252 sh |
| Jan 10, 2026Form 4 | Kelly Timothy EdwinChief Financial OfficerTax withholding · $385K · 1,335 sh |
| Jan 10, 2026Form 4 | Sniecinski MeganChief Operating OfficerTax withholding · $314K · 1,087 sh |
| Jan 10, 2026Form 4 | Nemiroff AlexGeneral Counsel and SecretaryTax withholding · $265K · 917 sh |
| Jan 10, 2026Form 4 | Mastrocola LaurenPrincipal Accounting OfficerTax withholding · $106K · 367 sh |
| Jan 8, 2026Form 4 | Souza MarcioChief Executive Officer · DirectorAward · $0 · 27,640 sh |
| Jan 8, 2026Form 4 | Souza MarcioChief Executive Officer · DirectorAward · Stock Option (Right to Buy) · $0 · 22,110 sh |
| Jan 8, 2026Form 4 | Sniecinski MeganChief Operating OfficerAward · $0 · 9,625 sh |
| Jan 8, 2026Form 4 | Kelly Timothy EdwinChief Financial OfficerAward · $0 · 8,800 sh |
| Jan 8, 2026Form 4 | Sniecinski MeganChief Operating OfficerAward · Stock Option (Right to Buy) · $0 · 7,700 sh |
| Jan 8, 2026Form 4 | Mastrocola LaurenPrincipal Accounting OfficerAward · Stock Option (Right to Buy) · $0 · 7,500 sh |
| Jan 8, 2026Form 4 | Kelly Timothy EdwinChief Financial OfficerAward · Stock Option (Right to Buy) · $0 · 7,040 sh |
| Jan 8, 2026Form 4 | Nemiroff AlexGeneral Counsel and SecretaryAward · $0 · 6,875 sh |
| Jan 8, 2026Form 4 | Nemiroff AlexGeneral Counsel and SecretaryAward · Stock Option (Right to Buy) · $0 · 5,500 sh |
| Jan 8, 2026Form 4 | Mastrocola LaurenPrincipal Accounting OfficerAward · $0 · 3,750 sh |
| Jan 7, 2026Form 4 | Souza MarcioChief Executive Officer · DirectorTax withholding · $119K · 405 sh |
| Jan 7, 2026Form 4 | Kelly Timothy EdwinChief Financial OfficerTax withholding · $41K · 139 sh |
| Jan 7, 2026Form 4 | Nemiroff AlexGeneral Counsel and SecretaryTax withholding · $26K · 89 sh |
| Jan 7, 2026Form 4 | Mastrocola LaurenPrincipal Accounting OfficerTax withholding · $10K · 35 sh |
Reports and proxy statements#
Annual reports (10-K, 20-F, 40-F), quarterly reports (10-Q), current reports (8-K, 6-K) and proxy statements, newest first. An 8-K that furnishes a press release is headed by the release’s headline, its items beneath; any other 8-K is described by its items. A form opens the press release where there is one, else the document on EDGAR, or the filing’s index where it furnishes other exhibits.
2026 · 20 filings
| Filed | What it is |
|---|---|
| Aug 6, 202610-Q | Quarterly report, Q2 2026 — net income −$83.7M, EPS −$2.87 |
| Aug 6, 20268-K | Earnings release — EPS −$2.87 vs −$3.60 est. (+20.3%) 16.0% |
| Jul 7, 20268-K | Other events |
| Jul 2, 20268-K | Change of auditor |
| Jun 29, 20268-K | Other events |
| Jun 22, 20268-K | Other events |
| Jun 12, 20268-K | Shareholder vote results |
| Jun 1, 20268-K | Other events |
| May 7, 20268-K | Earnings release — EPS −$3.20 vs −$3.58 est. (+10.6%) 1.0% |
| May 7, 202610-Q | Quarterly report, Q1 2026 — net income −$92.6M, EPS −$3.20 |
| Apr 30, 2026DEFA14A | Additional proxy materials |
| Apr 30, 2026DEF 14A | Proxy statement |
| Apr 14, 20268-K | Other events |
| Apr 6, 20268-K | Other events |
| Feb 19, 202610-K | Annual report, FY2025 — revenue $0 (−100% y/y), net income −$303.3M, EPS −$13.48 |
| Feb 19, 20268-K | Earnings release — EPS −$3.50 vs $3.00 est. (−16.7%); revenue $0 (−100% y/y) 0.8% |
| Feb 10, 20268-K/A | Directors or officers; compensation |
| Jan 8, 20268-K | Directors or officers; compensation |
| Jan 7, 20268-K | Other events |
| Jan 6, 20268-K | Results of operations |
2025 · 21 filings
| Filed | What it is |
|---|---|
| Dec 29, 20258-K | Other events |
| Dec 11, 20258-K | Other events |
| Dec 8, 20258-K | Other events |
| Nov 5, 202510-Q | Quarterly report, Q3 2025 — revenue $0 (−100% y/y), net income −$73.9M, EPS −$3.36 |
| Nov 5, 20258-K | Earnings release — EPS −$3.36 vs −$3.45 est. (+2.6%); revenue $0 (−100% y/y) 4.1% |
| Oct 21, 20258-K | Regulation FD disclosure; Other events |
| Oct 20, 20258-K | Other events |
| Oct 16, 20258-K | Regulation FD disclosure; Other events |
| Sep 5, 20258-K | Other events |
| Aug 4, 20258-K | Earnings release — EPS −$3.31 vs −$3.40 est. (+2.6%); revenue $0 (−100% y/y) 5.5% |
| Aug 4, 202510-Q | Quarterly report, Q2 2025 — revenue $0 (−100% y/y), net income −$71.1M, EPS −$3.31 |
| Jul 17, 20258-K | Regulation FD disclosure; Other events |
| Jun 27, 20258-K | Shareholder vote results |
| May 2, 20258-K | Regulation FD disclosure; Other events |
| May 2, 202510-Q | Quarterly report, Q1 2025 — revenue $0 (−100% y/y), net income −$69.3M, EPS −$3.29 |
| May 2, 20258-K | Earnings release — EPS −$3.29 vs −$3.20 est. (−2.8%); revenue $0 (−100% y/y) 5.7% |
| Apr 30, 2025DEFA14A | Additional proxy materials |
| Apr 30, 2025DEF 14A | Proxy statement |
| Feb 28, 202510-K | Annual report, FY2024 — revenue $8.6M (+250% y/y), net income −$182.8M, EPS −$10.21 |
| Feb 28, 20258-K | Earnings release — EPS −$2.94 vs −$2.96 est. (+0.7%); revenue $7.5M (+1349% y/y) 40.6% |
| Jan 29, 20258-K | Results of operations |
2024 · 18 filings
| Filed | What it is |
|---|---|
| Nov 6, 202410-Q | Quarterly report, Q3 2024 — revenue $302K (−35% y/y), net income −$51.9M, EPS −$2.75 |
| Nov 6, 20248-K | Earnings release — EPS −$2.75 vs −$2.01 est. (−36.8%); revenue $302K (−35% y/y) 1.2% |
| Oct 15, 20248-K | Directors or officers; compensation |
| Sep 3, 20248-K | Regulation FD disclosure; Other events |
| Aug 13, 202410-Q | Quarterly report, Q2 2024 — revenue $357K (−54% y/y), net income −$32.7M, EPS −$1.74 |
| Aug 13, 20248-K | Earnings release — EPS −$1.74 vs −$2.38 est. (+26.9%); revenue $357K (−54% y/y) 0.8% |
| Jun 6, 20248-K | Directors or officers; compensation; Shareholder vote results |
| May 13, 202410-Q | Quarterly report, Q1 2024 — revenue $431K (−37% y/y), net income −$39.6M, EPS −$2.84 |
| May 13, 20248-K | Earnings release — EPS −$2.84 vs −$2.01 est. (−41.3%); revenue $431K (−37% y/y) 7.4% |
| Apr 26, 2024DEFA14A | Additional proxy materials |
| Apr 26, 2024DEF 14A | Proxy statement |
| Mar 29, 20248-K | Other events |
| Mar 26, 20248-K | Other events |
| Mar 5, 20248-K | Earnings release — EPS −$2.97 vs −$3.15 est. (+5.7%); revenue $515K 1.9% |
| Mar 5, 202410-K | Annual report, FY2023 — revenue $2.4M, net income −$123.3M, EPS −$18.69 |
| Jan 12, 20248-K | Other events |
| Jan 11, 20248-K | Termination of a material agreement |
| Jan 10, 20248-K | Results of operations; Unregistered sale of equity; Other events |
2023 · 26 filings — 17 × 8-K, 3 × 10-Q, 2 × DEF 14A and 3 other forms
| Filed | What it is |
|---|---|
| Nov 7, 202310-Q | Quarterly report, Q3 2023 — revenue $468K, net income −$24.6M, EPS −$2.72 |
| Oct 16, 2023DEF 14A | Proxy statement |
| Oct 4, 2023PRE 14A | Preliminary proxy statement |
| Aug 9, 202310-Q | Quarterly report, Q2 2023 — revenue $781K, net income −$34.3M, EPS −$7.38 |
| Jun 5, 2023DEFA14A | Additional proxy materials |
| May 11, 202310-Q | Quarterly report, Q1 2023 — revenue $683K, net income −$37.5M, EPS −$10.58 |
| Apr 28, 2023DEFA14A | Additional proxy materials |
| Apr 28, 2023DEF 14A | Proxy statement |
| Feb 7, 202310-K | Annual report, FY2022 — revenue $0, net income −$214.0M, EPS −$69.65 |
17 current reports (8-K) not listed; the year is on EDGAR.
2022 · 23 filings — 15 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms
| Filed | What it is |
|---|---|
| Nov 9, 202210-Q | Quarterly report, Q3 2022 — revenue $0, net income −$43.9M, EPS −$0.96 |
| Aug 8, 202210-Q | Quarterly report, Q2 2022 — revenue $0, net income −$60.2M, EPS −$1.32 |
| May 23, 2022DEFA14A | Additional proxy materials |
| May 9, 202210-Q | Quarterly report, Q1 2022 — revenue $0, net income −$68.7M, EPS −$1.51 |
| Apr 14, 2022DEFA14A | Additional proxy materials |
| Apr 14, 2022DEF 14A | Proxy statement |
| Feb 28, 202210-K | Annual report, FY2021 — net income −$167.1M, EPS −$3.94 |
16 current reports (8-K) not listed; the year is on EDGAR.
2021 · 17 filings — 11 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
| Filed | What it is |
|---|---|
| Nov 3, 202110-Q | Quarterly report, Q3 2021 — net income −$44.7M, EPS −$1.00 |
| Aug 16, 202110-Q | Quarterly report, Q2 2021 — net income −$36.4M, EPS −$0.88 |
| May 11, 202110-Q | Quarterly report, Q1 2021 — net income −$27.4M, EPS −$0.71 |
| Apr 29, 2021DEFA14A | Additional proxy materials |
| Apr 29, 2021DEF 14A | Proxy statement |
| Mar 17, 202110-K | Annual report, FY2020 — net income −$61.8M, EPS −$7.86 |
11 current reports (8-K) not listed; the year is on EDGAR.
Insider, ownership and other filings#
Insider ownership (Forms 3, 4, 5 and 144), beneficial ownership (Schedules 13D and 13G), registration and prospectus (S-1, S-3, S-8, 424B and related) and the rest, counted by year, with the newest 25 of each of the latest 3 years shown. A Form 4 is one insider’s transaction report; a 13G is a passive holder above five percent.
2026 · 49 filings — 30 × 4, 8 × SCHEDULE 13G/A, 4 × SCHEDULE 13G and 4 other forms
| Filed | What it is |
|---|---|
| Aug 14, 2026SCHEDULE 13G/A | Other filings |
| Jul 8, 20264 | Insider transaction (Form 4) |
| Jun 26, 20264 | Insider transaction (Form 4) |
| Jun 24, 2026144 | Notice of proposed sale (Form 144) |
| Jun 12, 20264 | Insider transaction (Form 4) |
| Jun 12, 20264 | Insider transaction (Form 4) |
| Jun 12, 20264 | Insider transaction (Form 4) |
| Jun 12, 20264 | Insider transaction (Form 4) |
| Jun 12, 20264 | Insider transaction (Form 4) |
| Jun 12, 20264 | Insider transaction (Form 4) |
| Jun 12, 20264 | Insider transaction (Form 4) |
| Jun 12, 20264 | Insider transaction (Form 4) |
| May 19, 20264 | Insider transaction (Form 4) |
| May 19, 20264 | Insider transaction (Form 4) |
| May 19, 20264 | Insider transaction (Form 4) |
| May 19, 20264 | Insider transaction (Form 4) |
| May 19, 20264 | Insider transaction (Form 4) |
| May 15, 2026SCHEDULE 13G | Other filings |
| May 15, 2026SCHEDULE 13G/A | Other filings |
| May 15, 2026SCHEDULE 13G/A | Other filings |
| May 6, 2026SCHEDULE 13G/A | Other filings |
| Apr 30, 2026SCHEDULE 13G | Other filings |
| Mar 27, 2026SCHEDULE 13G/A | Other filings |
| Feb 19, 2026S-8 | Employee stock plan registration |
| Feb 17, 2026SCHEDULE 13G/A | Other filings |
The newest 25 of 49 shown; the full year is on EDGAR.
2025 · 60 filings — 25 × 4, 22 × SCHEDULE 13G/A, 5 × SCHEDULE 13G and 4 other forms
| Filed | What it is |
|---|---|
| Dec 31, 20254 | Insider transaction (Form 4) |
| Nov 21, 20254 | Insider transaction (Form 4) |
| Nov 21, 20254 | Insider transaction (Form 4) |
| Nov 21, 20254 | Insider transaction (Form 4) |
| Nov 20, 2025144 | Notice of proposed sale (Form 144) |
| Nov 20, 2025144 | Notice of proposed sale (Form 144) |
| Nov 14, 2025SCHEDULE 13G/A | Other filings |
| Nov 14, 2025SCHEDULE 13G/A | Other filings |
| Nov 14, 2025SCHEDULE 13G/A | Other filings |
| Nov 14, 2025SCHEDULE 13G/A | Other filings |
| Nov 7, 2025SCHEDULE 13G/A | Other filings |
| Nov 3, 2025SCHEDULE 13G/A | Other filings |
| Oct 20, 2025424B5 | Prospectus supplement |
| Oct 17, 20254 | Insider transaction (Form 4) |
| Oct 16, 2025424B5 | Prospectus supplement |
| Sep 25, 20254 | Insider transaction (Form 4) |
| Sep 5, 2025424B5 | Prospectus supplement |
| Sep 2, 2025SCHEDULE 13G/A | Other filings |
| Aug 19, 20253 | Initial insider holdings (Form 3) |
| Aug 14, 2025SCHEDULE 13G/A | Other filings |
| Aug 14, 2025SCHEDULE 13G/A | Other filings |
| Aug 14, 2025SCHEDULE 13G/A | Other filings |
| Aug 12, 2025SCHEDULE 13G/A | Other filings |
| Aug 5, 2025SCHEDULE 13G/A | Other filings |
| Jul 22, 2025SCHEDULE 13G | Other filings |
The newest 25 of 60 shown; the full year is on EDGAR.
2024 · 68 filings — 27 × 4, 20 × SC 13G/A, 7 × SC 13G and 9 other forms
| Filed | What it is |
|---|---|
| Dec 23, 2024S-3ASR | Automatic shelf registration |
| Nov 19, 20244 | Insider transaction (Form 4) |
| Nov 19, 20244 | Insider transaction (Form 4) |
| Nov 15, 20244 | Insider transaction (Form 4) |
| Nov 15, 20244 | Insider transaction (Form 4) |
| Nov 14, 2024SC 13G/A | Passive holder above 5% (Schedule 13G), amended |
| Nov 14, 2024SC 13G/A | Passive holder above 5% (Schedule 13G), amended |
| Nov 14, 2024SC 13G/A | Passive holder above 5% (Schedule 13G), amended |
| Nov 14, 2024SC 13G/A | Passive holder above 5% (Schedule 13G), amended |
| Nov 14, 2024144 | Notice of proposed sale (Form 144) |
| Nov 14, 2024144 | Notice of proposed sale (Form 144) |
| Nov 14, 2024SC 13G | Passive holder above 5% (Schedule 13G) |
| Nov 14, 2024SC 13G/A | Passive holder above 5% (Schedule 13G), amended |
| Nov 12, 2024SC 13G/A | Passive holder above 5% (Schedule 13G), amended |
| Nov 12, 2024SC 13G | Passive holder above 5% (Schedule 13G) |
| Nov 12, 2024SC 13G/A | Passive holder above 5% (Schedule 13G), amended |
| Nov 8, 2024SC 13G | Passive holder above 5% (Schedule 13G) |
| Nov 4, 2024SC 13G/A | Passive holder above 5% (Schedule 13G), amended |
| Oct 22, 2024SC 13G | Passive holder above 5% (Schedule 13G) |
| Sep 23, 2024SC 13G | Passive holder above 5% (Schedule 13G) |
| Jul 31, 20244 | Insider transaction (Form 4) |
| Jul 31, 20244 | Insider transaction (Form 4) |
| Jul 31, 20244 | Insider transaction (Form 4) |
| Jul 31, 20244 | Insider transaction (Form 4) |
| Jul 1, 2024SC 13G | Passive holder above 5% (Schedule 13G) |
The newest 25 of 68 shown; the full year is on EDGAR.
2023 · 60 filings — 31 × 4, 10 × SC 13G/A, 8 × SC 13G and 9 other forms
Counted, not listed; the year is on EDGAR.
2022 · 49 filings — 36 × 4, 6 × SC 13G/A, 5 × SC 13G and 2 other forms
Counted, not listed; the year is on EDGAR.
2021 · 48 filings — 25 × 4, 6 × SC 13G, 3 × 3 and 11 other forms
Counted, not listed; the year is on EDGAR.
2020 · 43 filings — 15 × 3, 7 × 4, 4 × CORRESP and 12 other forms
Counted, not listed; the year is on EDGAR.
2019 · 1 filing — 1 × D
Counted, not listed; the year is on EDGAR.
2018 · 1 filing — 1 × D
Counted, not listed; the year is on EDGAR.
2016 · 1 filing — 1 × D
Counted, not listed; the year is on EDGAR.
About this data#
Praxis Precision Medicines Inc. (PRAX) has 510 filings on EDGAR going back to 2016: 6 annual reports, 18 quarterly reports and 90 current reports, plus proxy statements, insider forms and ownership schedules. Its latest annual report, a 10-K, was filed on Feb 19, 2026 for the fiscal year ended Dec 31, 2025. The most recent 8-K, on Aug 6, 2026, furnished a press release headed “Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2026 Financial Results”. Over the last 13 months insiders sold $3.6M in 1 sale and bought nothing on the open market; 51 other transactions (awards, exercises, tax withholding, gifts and plan purchases). Not investment advice.
Every row is a filing EDGAR lists for the registrants that have been Praxis Precision Medicines Inc., read from the SEC’s submissions index each morning; a filing accepted after that read appears the next day. Where a company changed its filing entity (a holding-company reorganisation, Google into Alphabet) the predecessor’s filings are shown for the years it filed as the company, derived from the filings themselves. Dates are the filing date; the period is the report’s own. The latest 3 years of reports are listed in full, the next years to 10 without their 8-Ks, and older years are counted; the other forms are counted too, with the newest 25 of each of the latest 3 years shown. Insider transactions are the Form 4 and Form 5 documents themselves, filed since January 2026, every number as the insider filed it: a day’s lots are summed, a blank price adds its shares and no dollars, and a purchase through an employee stock plan is a plan purchase, not insider buying. An 8-K’s headline is the first line of the press release it furnishes (Exhibit 99), read from the filing and shown word for word; where two independent readings of the exhibit do not agree, the 8-K is described by its items instead. The documents stay on sec.gov, public domain, and every link opens the SEC’s copy. ChartRow does not summarise or interpret filings.
FAQ#
- Where can I read PRAX's latest 10-K?
- PRAX's latest annual report, a 10-K, was filed on Feb 19, 2026 for the fiscal year ended Dec 31, 2025. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.
- When did PRAX last file an 8-K?
- On Aug 6, 2026 it furnished a press release headed “Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2026 Financial Results”. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Aug 6, 2026.
- Are PRAX insiders buying or selling?
- Over the last 13 months insiders sold $3.6M in 1 sale and bought nothing on the open market; 51 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: DeSimone Jill (Director) sold 11,600 shares on Jun 24, 2026 for $3.6M, under a 10b5-1 plan. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.
- How many SEC filings has PRAX made?
- 510 filings are on EDGAR under the registrant records that have been Praxis Precision Medicines Inc., going back to 2016; 211 of them are insider ownership forms (Forms 3, 4, 5 and 144).